Implications of MTHFD2 expression in renal cell carcinoma aggressiveness
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0299353 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Rafaela V N Silva und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Genetics and Evolution, Institute of Biological and Natural Sciences, Federal University of Triângulo Mineiro, Uberaba, Mina…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de Minas Gerais, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Renal cell carcinoma (RCC) is the most common type of cancer in kidney and is often diagnosed in advanced stages. Until now, there is no reliable biomarker to assess tumor prognosis during histopathological diagnosis. The Methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) overexpression has been suggested as prognostic indicator for RCC, however, its protein profile needs to be clarified. This study investigated the MTHFD2 expression in different RCC cohorts, associating it with tumor characteristics and prognostic factors. Gene expression comparisons between non-neoplastic (NN) and tumor samples, as well as patients’ survival analysis, were assessed using KM-Plotter tool. MTHFD2 protein pattern was evaluated in 117 RCC by immunohistochemistry and associations with prognosis, clinical and pathological data were investigated. The tumors exhibited higher MTHFD2 transcript levels than NN, being even higher in the metastatic group. Opposite gene expression patterns were found among clear cell renal cell carcinoma (ccRCC) and pappilary renal cell carcinoma (pRCC) subtypes, showing higher and lower expressions compared to NN samples respectively. Overexpression was associated with shorter overall survival for ccRCC and pRCC subtypes, and shorter recurrence-free survival for pRCC. The immunolabeling profile varied according to tumor subtypes, with lower intensity and expression scores in ccRCC compared to pRCC and to chromophobe renal cell carcinoma (chRCC). MTHFD2 protein expression was associated with larger tumors and higher Fuhrman grades. Although prognostic value of protein immunostaining was not confirmed, patients with higher MTHFD2 tended to have lower survival rates in the pRCC group. The results highlight MTHFD2 different patterns according to RCC histological subtypes, revealing marked variations at both the genetic and protein levels. The mRNA indicated tumor prognosis, and greater expression in the tumor samples. Although MTHFD2 immunolabeling suggests tumor aggressiveness, it needs to be validated in other cohorts as potential prognostic factor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Genetics and Evolution, Institute of Biological and Natural Sciences, Federal University of Triângulo Mineiro, Uberaba, Minas Gerais, Brazil.
- Clinics Hospital, Federal University of Triângulo Mineiro, Uberaba, Minas Gerais, Brazil.
- Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
- Department of Clinical Surgery, Federal University of Triângulo Mineiro, Uberaba, Minas Gerais, Brazil.
ORCID-Profile: Régia C P Lira
Förderung
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Silva, R. V. N., Berzotti, L. A., Laia, M. G., Araújo, L. S., Silva, C. A., Ribeiro, K. B., Brandão, M., Michelleti, A. M. R., Machado, J. R., & Lira, R. C. P. (2024). Implications of MTHFD2 expression in renal cell carcinoma aggressiveness. PLOS ONE. https://doi.org/10.1371/journal.pone.0299353
Vancouver
Silva RVN, Berzotti LA, Laia MG, Araújo LS, Silva CA, Ribeiro KB, et al. Implications of MTHFD2 expression in renal cell carcinoma aggressiveness. PLOS ONE. 2024. doi:10.1371/journal.pone.0299353
BibTeX
@article{Silva2024,
author = {Silva, Rafaela V N and Berzotti, Lucas A and Laia, Marcella G and Araújo, Liliane S and Silva, Crislaine A and Ribeiro, Karen B and Brandão, Millena and Michelleti, Adilha M R and Machado, Juliana R and Lira, Régia C P},
title = {Implications of MTHFD2 expression in renal cell carcinoma aggressiveness},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0299353}
}
EUVIMED